Saltar al contenido

Teladoc Health, Inc. (TDOC) stock: revenue, earnings & dividend

Teladoc Health, Inc. (TDOC, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener TDOC · NYSE Gesundheitswesen US-NY

Key figures

Fiscal year
2025
Revenue
2.53 bn $
Revenue growth
-1.5 %
Revenue growth 5y (p.a.)
18.3 %
Net income
-200.32 m $
Net margin
-7.9 %
Operating margin
-10.4 %
Earnings per share (diluted)
-1.14 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.86 bn $
Equity
1.39 bn $
Equity ratio
48.5 %
Return on equity
-14.5 %
Cash
781 m $
Operating cash flow
294 m $
Free cash flow
285 m $
Shares outstanding
182,293,675

History

Revenue by fiscal year

2016 123 m $
2017 233 m $
2018 418 m $
2020 1.09 bn $
2021 2.03 bn $
2022 2.41 bn $
2023 2.6 bn $
2024 2.57 bn $
2025 2.53 bn $

Net income by fiscal year

2016 -74.22 m $
2017 -106.78 m $
2018 -97.08 m $
2019 -98.86 m $
2020 -485.14 m $
2021 -428.79 m $
2022 -13.66 bn $
2023 -220.37 m $
2024 -1 bn $
2025 -200.32 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.53 bn $-200.32 m $-1.14 $–294 m $
20242.57 bn $-1 bn $-5.87 $–294 m $
20232.6 bn $-220.37 m $-1.34 $–350 m $
20222.41 bn $-13.66 bn $-84.60 $–189 m $
20212.03 bn $-428.79 m $-2.73 $–194 m $
20201.09 bn $-485.14 m $-5.36 $–-53.51 m $
2019–-98.86 m $-1.38 $–29.9 m $
2018418 m $-97.08 m $––-4.86 m $
2017233 m $-106.78 m $––-34.44 m $
2016123 m $-74.22 m $––-51.88 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)